These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35245485)

  • 1. Uremic toxins activate CREB/ATF1 in endothelial cells related to chronic kidney disease.
    Stafim da Cunha R; Gregório PC; Maciel RAP; Favretto G; Franco CRC; Gonçalves JP; de Azevedo MLV; Pecoits-Filho R; Stinghen AEM
    Biochem Pharmacol; 2022 Apr; 198():114984. PubMed ID: 35245485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and Cellular Mechanisms that Induce Arterial Calcification by Indoxyl Sulfate and P-Cresyl Sulfate.
    Opdebeeck B; D'Haese PC; Verhulst A
    Toxins (Basel); 2020 Jan; 12(1):. PubMed ID: 31963891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Uremic Toxins on Endothelial Dysfunction in Chronic Kidney Disease: A Systematic Review.
    Harlacher E; Wollenhaupt J; Baaten CCFMJ; Noels H
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
    Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
    Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC; Tomino Y; Lu KC
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Organic Anion Transporters in the Uptake of Protein-Bound Uremic Toxins by Human Endothelial Cells and Monocyte Chemoattractant Protein-1 Expression.
    Favretto G; Souza LM; Gregório PC; Cunha RS; Maciel RAP; Sassaki GL; Toledo MG; Pecoits-Filho R; Souza WM; Stinghen AEM
    J Vasc Res; 2017; 54(3):170-179. PubMed ID: 28472795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uremic endothelial-derived extracellular vesicles: Mechanisms of formation and their role in cell adhesion, cell migration, inflammation, and oxidative stress.
    Favretto G; da Cunha RS; Flores Santos A; Leitolis A; Schiefer EM; Gregório PC; Franco CRC; Massy Z; Dalboni MA; Stinghen AEM
    Toxicol Lett; 2021 Sep; 347():12-22. PubMed ID: 33945863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease.
    Fourdinier O; Glorieux G; Brigant B; Diouf M; Pletinck A; Vanholder R; Choukroun G; Verbeke F; Massy ZA; Metzinger-Le Meuth V; Metzinger L; Group-EUTox OBOTEUTW
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin enhances p-cresyl sulfate-induced cytotoxic effects on renal tubular cells.
    Wei CW; Wu TK; Wu SC; Chen YL; Pan YR; Chien YC; Wu JY; Yu YL; Yiang GT
    Int J Med Sci; 2022; 19(7):1138-1146. PubMed ID: 35919818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.
    Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
    J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uremic toxin indoxyl sulfate induces dysfunction of vascular smooth muscle cells via integrin-β1/ERK signaling pathway.
    Yu H; Zhou C; Hu D; Li C; Wang Q; Xue W; Peng A
    Clin Exp Nephrol; 2022 Jul; 26(7):640-648. PubMed ID: 35333997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-Bound Uremic Toxins and Immunity.
    Rocchetti MT; Cosola C; Ranieri E; Gesualdo L
    Methods Mol Biol; 2021; 2325():215-227. PubMed ID: 34053061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLC22A11 Inserts the Uremic Toxins Indoxyl Sulfate and P-Cresol Sulfate into the Plasma Membrane.
    Tust M; Müller JP; Fischer D; Gründemann D
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uremia Impacts VE-Cadherin and ZO-1 Expression in Human Endothelial Cell-to-Cell Junctions.
    Maciel RAP; Cunha RS; Busato V; Franco CRC; Gregório PC; Dolenga CJR; Nakao LS; Massy ZA; Boullier A; Pecoits-Filho R; Stinghen AEM
    Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30301260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients.
    Wu PH; Lin YT; Chiu YW; Baldanzi G; Huang JC; Liang SS; Lee SC; Chen SC; Hsu YL; Kuo MC; Hwang SJ
    Sci Rep; 2021 Feb; 11(1):3786. PubMed ID: 33589722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of uremic toxins in advanced chronic kidney disease patients on maintenance hemodialysis by LC-ESI-MS/MS.
    Ragi N; Pallerla P; Babi Reddy Gari AR; Lingampelly SS; Ketavarapu V; Addipilli R; Chirra N; Kantevari S; Yadla M; Sripadi P
    Metabolomics; 2023 Feb; 19(3):14. PubMed ID: 36826619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Resveratrol Supplementation Reduce Uremic Toxin Plasma Levels From the Gut Microbiota in Nondialyzed Patients With Chronic Kidney Disease?
    Alvarenga L; Cardozo LFMF; Leal VO; Kemp JA; Saldanha JF; Ribeiro-Alves M; Meireles T; Nakao LS; Mafra D
    J Ren Nutr; 2022 Nov; 32(6):685-691. PubMed ID: 35122992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P
    Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
    Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
    Sato E; Saigusa D; Mishima E; Uchida T; Miura D; Morikawa-Ichinose T; Kisu K; Sekimoto A; Saito R; Oe Y; Matsumoto Y; Tomioka Y; Mori T; Takahashi N; Sato H; Abe T; Niwa T; Ito S
    Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29283413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.